Drug intelligence / Profile preview

Shi-cha capsule

Development stage: Unknown
Lead developer: West China Hospital of Sichuan University
Administration: Oral

Overview

Shi-cha capsule is a Traditional Chinese Medicine (TCM) herbal formula developed by the Department of Integrated Traditional Chinese and Western Medicine at West China Hospital, Sichuan University. It is specifically formulated for the treatment of the "wind-cold" type of the common cold. The formula is designed to alleviate symptoms such as fever, chills, headache, and nasal congestion associated with viral upper respiratory tract infections. As a botanical product, its mechanism likely involves a multi-target approach including anti-inflammatory, antiviral, and antipyretic activities derived from its constituent herbs. It has been evaluated in clinical trials to determine its therapeutic efficacy, safety, and optimal dosage.

Brand names: Shi-cha capsule
Other names: Shicha capsule

Beyond the preview

Go deeper on Shi-cha capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shi-cha capsule.

Explore the full profile